Aptose Biosciences secures funds for AML treatment development
Pharmaceutical Technology
SEPTEMBER 2, 2024
Aptose Biosciences has secured a loan of $10m through a facility agreement with Hanmi Pharmaceutical to develop tuspetinib.
Mon.Sep 02, 2024
275 
As mpox cases rise over 18,000, UNICEF tenders for vaccines
pharmaphorum
SEPTEMBER 2, 2024
UNICEF has issued an emergency tender to secure mpox vaccines for countries dealing with the brunt of the current outbreak
Join 21,000+
Insiders
Sign Up for our Newsletter
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Novavax wins FDA emergency approval for updated Covid-19 vaccine
Pharmaceutical Technology
SEPTEMBER 2, 2024
The US regulatory agency has also approved updated versions of Covid-19 vaccines from Moderna and Pfizer / BioNTech’s in the past two weeks.
Two of three trials fail, but Sanofi will still file MS drug
pharmaphorum
SEPTEMBER 2, 2024
Sanofi eyes filings for multiple sclerosis therapy tolebrutinib, although two of three phase 3 trials miss their primary endpoints
From Diagnosis to Delivery: How AI is Revolutionizing the Patient Experience
Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.
The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven
ESC 2024: GLP-1RAs show lower CV risk in 32,883-strong meta-analysis
Pharmaceutical Technology
SEPTEMBER 2, 2024
GLP-1RAs’ reduce CV risk, including reducing all-cause mortality and risk of MI, promoting weight loss and enhancing blood pressure control.
iRhythm wearable heart monitor raises AFib diagnoses by 52%
pharmaphorum
SEPTEMBER 2, 2024
iRhythm's Zio XT wearable heart monitor raises AFib diagnoses by 52%, but doesn't reduce stroke hospitalisations in GUARD-AF trial.
Sign up to get articles personalized to your interests!
Clinical Research Informer brings together the best content for clinical researchers from the widest variety of industry thought leaders.
More Trending
GLP-1 Receptor Agonist Use and Risk of Suicide Death
JAMA Internal Medicine
SEPTEMBER 2, 2024
This cohort study assesses the association between use of glucagon-like peptide-1 receptor agonists and the risk of suicide death in routine clinical practice.
PHC uses LiCellGrow prototype for cell and gene therapy manufacture
Pharmaceutical Technology
SEPTEMBER 2, 2024
PHC Corporation has introduced a prototype of LiCellGrow, a cell expansion system designed to manufacture cell and gene therapy products.
BIA sends message to UK chancellor on R&D tax credits
pharmaphorum
SEPTEMBER 2, 2024
Biotech industry body BIA calls for new UK Chancellor Rachel Reeves to take sector-specific approach to R&D tax credits to tackle widespread fraud and abuse of the system.
The value of CNS-specific eCOA provider in clinical trials
Pharmaceutical Technology
SEPTEMBER 2, 2024
The pharmaceutical industry is continuously evolving, driven by the imperative to develop more effective and personalized treatments.
Best Practices for Implementing a Comprehensive Drug Safety Solution
Cloudbyz
SEPTEMBER 2, 2024
1. Define Clear Objectives and Requirements Defining clear objectives and requirements is the cornerstone of a successful drug safety solution implementation. It begins with a deep understanding of the organization’s strategic goals, regulatory obligations, and operational needs. This process involves not only identifying what the organization aims to achieve—such as improved regulatory compliance, enhanced adverse event management, or better integration with existing systems—but also understand
ESC 2024: Emerging data on novel therapeutic strategies for targeting lipids
Pharmaceutical Technology
SEPTEMBER 2, 2024
New insights on the PACMAN-AMI trial for patients with acute myocardial infarction are presented at the ESC Congress, among other updates.
Cardinal Health Introduces New Tennessee Advanced Therapy Innovation Center
Pharmaceutical Commerce
SEPTEMBER 2, 2024
The 8,000 square-foot facility—located within the wholesaler’s Le Vergne distribution center— is expected to help tackle cell and gene therapy logistical challenges.
ESC 2024: Single-pill hypertension combo delivers positive results
Pharmaceutical Technology
SEPTEMBER 2, 2024
A single-pill combination could present a better option for hypertension patients, said researchers at the ESC congress.
The New Age of Decentralized Clinical Trials
Advertisement
White paper that delves into the complex topic of Decentralized Clinical Trials and how to master them within the confines of FDA Regulations
Screening Mammography for 40-Year-Old Women
JAMA Internal Medicine
SEPTEMBER 2, 2024
This Viewpoint discusses the potential risks and benefits for starting screening at 40 rather than 50 years of age and whether clinicians or patients should decide based on risk rather than age.
Johnson & Johnson picks Onco360 as pharmacy partner for LAZCLUZE
Pharmaceutical Technology
SEPTEMBER 2, 2024
Johnson & Johnson has selected Onco360 as a pharmacy partner for the distribution of LAZCLUZE (lazertinib).
Psychiatric Safety of Semaglutide for Weight Management in People Without Known Major Psychopathology
JAMA Internal Medicine
SEPTEMBER 2, 2024
This post hoc analysis of 4 randomized clinical trials evaluate the psychiatric safety of subcutaneous semaglutide, 2.4 mg, once weekly in people with obesity or overweight without known major psychopathology.
Jacobio Pharma grants Allist rights to two assets in China
Pharmaceutical Technology
SEPTEMBER 2, 2024
Jacobio Pharma has out-licensed the China rights of its assets, glecirasib and JAB-3312, to Shanghai Allist Pharmaceuticals.
Let's personalize your content